January 27, 2015 8:27 AM ET

Biotechnology

Company Overview of Alinea Pharmaceuticals, Inc.

Company Overview

Alinea Pharmaceuticals, Inc. develops and commercializes biopharmaceutical therapeutic products for the treatment of diabetes and related metabolic disorders. The company’s products include Aldose Reductase Inhibitors, a rate controlling enzyme in the polyol pathway of glucose metabolism whereby excess glucose is converted into fructose and sorbitol in tissues, such as the retina, kidney, and nerves. It also offers Phosphotyrosine Phosphatase, which involves in insulin and leptin signaling and a mechanism for down-regulating the insulin and leptin receptor signaling pathways. Alinea Pharmaceuticals, Inc. was founded in 2005 and is based in Cambridge, Massachusetts.

One Memorial Drive

Suite 1225

Cambridge, MA 02142-1313

United States

Founded in 2005

Phone:

617-914-0123

Fax:

617-914-0122

Key Executives for Alinea Pharmaceuticals, Inc.

Senior Medical Advisor
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Cancer Targeting Systems, Inc. United States
Advent Therapeutics, Inc. United States
Agradis, Inc. United States
Visionary Pharmaceuticals, Inc. United States
Akermin, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Alinea Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.